COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
作者信息
Marmor Michael F
机构信息
Department of Ophthalmology and Byers Eye Institute, Stanford University School of Medicine, Palo Alto, California.
出版信息
Am J Ophthalmol. 2020 Aug;216:A1-A2. doi: 10.1016/j.ajo.2020.03.029. Epub 2020 May 8.
Abstract
摘要
相似文献
1
COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?2019冠状病毒病与氯喹/羟氯喹：是否存在眼科方面的问题？
Am J Ophthalmol. 2020 Aug;216:A1-A2. doi: 10.1016/j.ajo.2020.03.029. Epub 2020 May 8.
2
Hydroxychloroquine and ritonavir for COVID-19 infection: a possible synergic toxicity for retinal pigmented epithelium.羟氯喹啉和利托那韦用于治疗新型冠状病毒肺炎感染：对视网膜色素上皮细胞可能存在协同毒性。
Graefes Arch Clin Exp Ophthalmol. 2020 Dec;258(12):2871. doi: 10.1007/s00417-020-04727-3. Epub 2020 May 8.
3
Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.氯喹和羟氯喹在2019冠状病毒病中的应用：资源匮乏地区面临的挑战及谨慎使用的必要性
J Coll Physicians Surg Pak. 2020 Jun;30(6):78. doi: 10.29271/jcpsp.2020.Supp1.S78.
4
COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?新型冠状病毒肺炎与氯喹/羟氯喹：是否存在眼科方面的问题？
Am J Ophthalmol. 2020 May;213:A3-A4. doi: 10.1016/j.ajo.2020.03.028. Epub 2020 Mar 25.
5
Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19.氯喹和羟氯喹治疗 COVID-19 时的视网膜毒性考虑。
Asia Pac J Ophthalmol (Phila). 2020 Mar-Apr;9(2):85-87. doi: 10.1097/APO.0000000000000289.
6
[Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?].在此次新冠疫情期间短期使用羟氯喹治疗的情况下，是否需要进行眼科监测？
J Fr Ophtalmol. 2020 Jun;43(6):548-549. doi: 10.1016/j.jfo.2020.04.014. Epub 2020 Apr 30.
7
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.氯喹和羟氯喹用于治疗新型冠状病毒肺炎的安全性考量
Clin Microbiol Infect. 2020 Sep;26(9):1276-1277. doi: 10.1016/j.cmi.2020.05.006. Epub 2020 May 16.
8
Of chloroquine and COVID-19.关于氯喹和 COVID-19。
Antiviral Res. 2020 May;177:104762. doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5.
9
Rheumotologitsts' view on the use of hydroxychloroquine to treat COVID-19.风湿科医生对羟氯喹治疗 COVID-19 的看法。
Emerg Microbes Infect. 2020 Dec;9(1):830-832. doi: 10.1080/22221751.2020.1760145.
10
Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).关于氯喹/羟氯喹治疗 2019 年冠状病毒病（COVID-19）的最新情况。
Biosci Trends. 2020 May 21;14(2):156-158. doi: 10.5582/bst.2020.03072. Epub 2020 Apr 13.
引用本文的文献
1
A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19.关于COVID-19的药物制剂、免疫疗法和支持性疗法的全面综述。
Narra J. 2022 Dec;2(3):e92. doi: 10.52225/narra.v2i3.92. Epub 2022 Dec 8.
2
Recommendations for eye care during the alarm state by the coronavirus disease pandemic COVID-19.2019冠状病毒病（COVID-19）大流行警戒状态下的眼部护理建议。
Arch Soc Esp Oftalmol (Engl Ed). 2020 Jun;95(6):300-310. doi: 10.1016/j.oftal.2020.04.002. Epub 2020 Apr 25.
本文引用的文献
1
Coronavirus puts drug repurposing on the fast track.冠状病毒使药物重新利用走上快车道。
Nat Biotechnol. 2020 Apr;38(4):379-381. doi: 10.1038/d41587-020-00003-1.
2
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
3
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?氯喹抗冠状病毒的抗病毒作用的新见解：对 COVID-19 有何期待？
Int J Antimicrob Agents. 2020 May;55(5):105938. doi: 10.1016/j.ijantimicag.2020.105938. Epub 2020 Mar 12.
4
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.突破：磷酸氯喹在临床研究中显示出对 COVID-19 相关肺炎的明显疗效。
Biosci Trends. 2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
5
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).关于氯喹和羟氯喹视网膜病变筛查的建议（2016 年修订版）。
Ophthalmology. 2016 Jun;123(6):1386-94. doi: 10.1016/j.ophtha.2016.01.058. Epub 2016 Mar 16.
6
Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.用于癌症治疗的高剂量羟氯喹导致视网膜毒性迅速发作。
Am J Ophthalmol. 2015 Oct;160(4):799-805.e1. doi: 10.1016/j.ajo.2015.07.012. Epub 2015 Jul 17.
7
The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.长期羟氯喹治疗患者中毒性视网膜病变的风险。
JAMA Ophthalmol. 2014 Dec;132(12):1453-60. doi: 10.1001/jamaophthalmol.2014.3459.
8
Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma.联合抑制哺乳动物雷帕霉素靶蛋白（mTOR）和自噬：羟氯喹和替西罗莫司治疗晚期实体瘤和黑色素瘤患者的I期试验
Autophagy. 2014 Aug;10(8):1391-402. doi: 10.4161/auto.29119. Epub 2014 May 20.
9
Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma.自噬与蛋白酶体联合抑制：羟氯喹啉和硼替佐米对复发/难治性骨髓瘤患者的1期试验
Autophagy. 2014 Aug;10(8):1380-90. doi: 10.4161/auto.29264. Epub 2014 May 20.
10
Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis.类风湿关节炎患者中羟氯喹的浓度-反应关系。
Arthritis Rheum. 2002 Jun;46(6):1460-9. doi: 10.1002/art.10307.
Zotero 插件